KM-1468

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameKM-1468

Drug Alias NameIGF-1/IGF-2 mAb (Kyowa Hakko Kogyo)monoclonal antibody IGF-1/IGF-2 (Kyowa Hakko Kogyo)KM-1468KM-3168

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionInsulin-like growth factor I receptor antagonistsInsulin-like growth factor II receptor inhibitorsAnticancer protein kinase inhibitors

TargetsInsulin-like growth factor II receptorInsulin-like growth factor I receptor

Therapy Area/IndicationsNeoplasm Metastasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKyowa Hakko Kogyo Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKyowa Hakko Kogyo Co Ltd

Active IndicationsN/A

Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A